TORONTO (PRWEB) OCTOBER 27, 2021 — Patient recruitment comprises one of the most significant initial challenges in any oncology study but engaging and retaining these patients throughout the clinical trial can ultimately be the challenge requiring the most upfront planning and coordination. However, during initial planning, the focus is usually placed predominately on recruitment and not on patient engagement efforts. This lapse undermines retention rates and potentially negatively impacts the patient experience, thereby reducing the possibility of each patient’s participation in future clinical trials.
If a study must replace patients, it adds expense for the sponsor and timeline delays. Many modern clinical trials, particularly in oncology, also include a long-term follow-up element. A patient who isn’t adequately engaged will not complete follow-up long term — if they even stay throughout the treatment portion of the study. Consequently, the sponsor’s submission goals could suffer because they don’t have adequate data, necessitating the enrollment of more patients or an additional trial.
In this free webinar, the featured speakers will discuss how regulators are signaling a trend toward a greater emphasis on patient engagement earlier in the study process, including the FDA’s recently launched Patient Engagement Collaborative Strategies. The presentation will highlight how engaging and supporting patients early in the study process improves study outcomes by contributing to a fuller understanding of the patient disease journey, including both the patient’s treatment and emotional pathway.
Join Premier Research’s Ashley Herrick, PhD, Executive Director, Oncology Program Strategy and Nicole Carswell, Executive Director, Patient Engagement & Recruitment, for the live webinar on Wednesday, October 27, 2021 at 1pm EDT.
For more information, or to register for this event, visit Empowering Oncology Patients to Maximize Study Outcomes: Strategies and Considerations for Sponsors.